High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep29177.pdf
Reference31 articles.
1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA: a cancer journal for clinicians 64, 9–29, doi: 10.3322/caac.21208 (2014).
2. Yang, L., Parkin, D. M., Ferlay, J., Li, L. & Chen, Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14, 243–250 (2005).
3. Escudier, B. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 23, Suppl 7, vii65–71, doi: 10.1093/annonc/mds227 (2012).
4. Jayson, M. & Sanders, H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51, 203–205 (1998).
5. Tsui, K. H. et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. The Journal of urology 163, 426–430 (2000).
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?;Cancers;2024-01-23
2. A novel prognostic N7-methylguanosine-related long non-coding RNA signature in clear cell renal cell carcinoma;Scientific Reports;2023-10-27
3. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics;International Immunopharmacology;2023-05
4. Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-01
5. Complement and Cancer Immunity;Handbook of Cancer and Immunology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3